Allergan Doesn’t Oppose MDL For Biocell Breast Implants But Suggests New Jersey
WASHINGTON, D.C. — Allergan Inc. on Nov. 1 told a federal judicial panel that it does not opposed centralization of 17 federal medical monitoring lawsuits involving Biocell textured breast implants but...To view the full article, register now.
Already a subscriber? Click here to view full article